Australia markets closed

Eli Lilly and Company (0Q1G.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
540.00+295.04 (+120.45%)
As of 04:18PM BST. Market open.
Currency in CHF

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 30.00%
S&P500 52-week change 322.64%
52-week high 3540.00
52-week low 30.00
50-day moving average 3540.00
200-day moving average 3540.00

Share statistics

Avg vol (3-month) 35k
Avg vol (10-day) 35k
Shares outstanding 51.01B
Implied shares outstanding 6N/A
Float 8897.84M
% held by insiders 10.16%
% held by institutions 184.34%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 34.52
Trailing annual dividend yield 31.85%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 15.36%
Operating margin (ttm)34.14%

Management effectiveness

Return on assets (ttm)11.88%
Return on equity (ttm)48.44%

Income statement

Revenue (ttm)34.12B
Revenue per share (ttm)37.91
Quarterly revenue growth (yoy)28.10%
Gross profit (ttm)N/A
EBITDA 12.31B
Net income avi to common (ttm)5.24B
Diluted EPS (ttm)6.52
Quarterly earnings growth (yoy)13.00%

Balance sheet

Total cash (mrq)3.04B
Total cash per share (mrq)3.38
Total debt (mrq)26.47B
Total debt/equity (mrq)243.63%
Current ratio (mrq)0.94
Book value per share (mrq)11.98

Cash flow statement

Operating cash flow (ttm)4.24B
Levered free cash flow (ttm)236.88M